Mahbubeh Sheikhzadeh, Fereshteh Bagheri, Mohammad Ali Bayani, Milad Kami, Mohsen Monadi
{"title":"评估 2 型糖尿病患者的听觉脑干反应测试。","authors":"Mahbubeh Sheikhzadeh, Fereshteh Bagheri, Mohammad Ali Bayani, Milad Kami, Mohsen Monadi","doi":"10.22088/cjim.15.3.527","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hearing loss is an unknown complication of diabetes mellitus (DM). The aim of this study was to evaluate hearing function using auditory brainstem response (ABR) in diabetic patients.</p><p><strong>Methods: </strong>The present case-control study was performed on thirty diabetic patients as a case group and thirty healthy individuals as a control group. Baseline demographic information, HbA1c level, and duration of diabetes were obtained from all diabetic patients. In all subjects, the ABR and pure-tone audiometry (PTA) tests were performed and the results were analyzed using the t-test and logistic regression.</p><p><strong>Results: </strong>The absolute latency of I was significantly lower in diabetes patients. The absolute latency of III and the interpeak latencies (IPL) I-III were significantly higher in diabetic patients. No significant relationship was noticed in the absolute latency of V and the IPL I-V among diabetic patients in the right and left ears (P>0.05).</p><p><strong>Conclusion: </strong>The results of this study suggested that diabetes may cause central auditory dysfunction manifested on the absolute latency of III, the IPL I-III and III-V.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"15 3","pages":"527-534"},"PeriodicalIF":0.8000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11246675/pdf/","citationCount":"0","resultStr":"{\"title\":\"Evaluation of the auditory brainstem response test in patients with type 2 diabetes mellitus.\",\"authors\":\"Mahbubeh Sheikhzadeh, Fereshteh Bagheri, Mohammad Ali Bayani, Milad Kami, Mohsen Monadi\",\"doi\":\"10.22088/cjim.15.3.527\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Hearing loss is an unknown complication of diabetes mellitus (DM). The aim of this study was to evaluate hearing function using auditory brainstem response (ABR) in diabetic patients.</p><p><strong>Methods: </strong>The present case-control study was performed on thirty diabetic patients as a case group and thirty healthy individuals as a control group. Baseline demographic information, HbA1c level, and duration of diabetes were obtained from all diabetic patients. In all subjects, the ABR and pure-tone audiometry (PTA) tests were performed and the results were analyzed using the t-test and logistic regression.</p><p><strong>Results: </strong>The absolute latency of I was significantly lower in diabetes patients. The absolute latency of III and the interpeak latencies (IPL) I-III were significantly higher in diabetic patients. No significant relationship was noticed in the absolute latency of V and the IPL I-V among diabetic patients in the right and left ears (P>0.05).</p><p><strong>Conclusion: </strong>The results of this study suggested that diabetes may cause central auditory dysfunction manifested on the absolute latency of III, the IPL I-III and III-V.</p>\",\"PeriodicalId\":9646,\"journal\":{\"name\":\"Caspian Journal of Internal Medicine\",\"volume\":\"15 3\",\"pages\":\"527-534\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11246675/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Caspian Journal of Internal Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22088/cjim.15.3.527\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Caspian Journal of Internal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22088/cjim.15.3.527","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:听力损失是糖尿病(DM)的一种未知并发症。本研究旨在利用听性脑干反应(ABR)评估糖尿病患者的听力功能:本病例对照研究以 30 名糖尿病患者为病例组,30 名健康人为对照组。研究人员获得了所有糖尿病患者的基线人口学信息、HbA1c 水平和糖尿病病程。对所有受试者进行 ABR 和纯音测听(PTA)测试,并使用 t 检验和逻辑回归对结果进行分析:结果:糖尿病患者 I 的绝对潜伏期明显较低。结果:糖尿病患者 I 峰绝对潜伏期明显较低,III 峰绝对潜伏期和 I-III 峰间潜伏期(IPL)明显较高。糖尿病患者左右耳的 V 绝对潜伏期和 IPL I-V 无明显关系(P>0.05):本研究结果表明,糖尿病可能导致中枢听觉功能障碍,表现在 III 绝对潜伏期、IPL I-III 和 III-V。
Evaluation of the auditory brainstem response test in patients with type 2 diabetes mellitus.
Background: Hearing loss is an unknown complication of diabetes mellitus (DM). The aim of this study was to evaluate hearing function using auditory brainstem response (ABR) in diabetic patients.
Methods: The present case-control study was performed on thirty diabetic patients as a case group and thirty healthy individuals as a control group. Baseline demographic information, HbA1c level, and duration of diabetes were obtained from all diabetic patients. In all subjects, the ABR and pure-tone audiometry (PTA) tests were performed and the results were analyzed using the t-test and logistic regression.
Results: The absolute latency of I was significantly lower in diabetes patients. The absolute latency of III and the interpeak latencies (IPL) I-III were significantly higher in diabetic patients. No significant relationship was noticed in the absolute latency of V and the IPL I-V among diabetic patients in the right and left ears (P>0.05).
Conclusion: The results of this study suggested that diabetes may cause central auditory dysfunction manifested on the absolute latency of III, the IPL I-III and III-V.